Prosecution Insights
Last updated: April 19, 2026

Ovid Therapeutics Inc.

2 pending office actions

Portfolio Summary

2
Total Pending OAs
1
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
18428488 METHODS OF TREATING SEIZURE DISORDERS AND PRADER-WILLI SYNDROME KOSTURKO, GEORGE W 1621 Final Rejection Jan 31, 2024
18347732 USE OF (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF CANCER MOTEVALLI, OROD 1628 Non-Final OA Jul 06, 2023

Managing Ovid Therapeutics Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month